+
データを開く
-
基本情報
| 登録情報 | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| タイトル | Structure of human SLC2A9 transporter | |||||||||
マップデータ | Sharpen final map after refinement | |||||||||
試料 |
| |||||||||
キーワード | Transporter / MEMBRANE PROTEIN | |||||||||
| 機能・相同性 | 機能・相同性情報Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) / fructose transmembrane transporter activity / fructose transmembrane transport / dehydroascorbic acid transport / hexose transmembrane transport / carbohydrate:proton symporter activity / Cellular hexose transport / D-glucose transmembrane transporter activity / D-glucose transmembrane transport / urate transport ...Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) / fructose transmembrane transporter activity / fructose transmembrane transport / dehydroascorbic acid transport / hexose transmembrane transport / carbohydrate:proton symporter activity / Cellular hexose transport / D-glucose transmembrane transporter activity / D-glucose transmembrane transport / urate transport / urate metabolic process / urate transmembrane transporter activity / D-glucose import / transmembrane transporter activity / electron transport chain / basolateral plasma membrane / periplasmic space / electron transfer activity / apical plasma membrane / iron ion binding / heme binding / membrane / plasma membrane 類似検索 - 分子機能 | |||||||||
| 生物種 | Homo sapiens (Human) (ヒト) / Homo sapiens (ヒト) | |||||||||
| 手法 | 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 3.37 Å | |||||||||
データ登録者 | Khandelwal NK / Gupta M / Stroud RM | |||||||||
| 資金援助 | 米国, 1件
| |||||||||
引用 | ジャーナル: Proc Natl Acad Sci U S A / 年: 2025タイトル: Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter. 著者: Nitesh Kumar Khandelwal / Meghna Gupta / Paras Kumar / Sree Ganesh Balasubramani / Ignacia Echeverria / Robert M Stroud / ![]() 要旨: Urate provides ~50% of the reducing potential in human and primate plasma which is key to detoxifying reactive oxygen by-products of cellular metabolism. Urate is the endpoint of purine metabolism in ...Urate provides ~50% of the reducing potential in human and primate plasma which is key to detoxifying reactive oxygen by-products of cellular metabolism. Urate is the endpoint of purine metabolism in primates, and its concentration in plasma is a balance between excretion from kidney and intestine, and subsequent reabsorption in and through cells of kidney proximal tubules to maintain a regulated concentration in plasma. SLC2A9 is the primary transporter that returns urate from the basolateral side of kidney tubule cells back to plasma. A shorter splice variant of SLC2A9 is directed to the apical surface where several transporters recapture urate from the tubule back into cells. Too high a concentration in plasma causes hyperuricemia, is linked to gout, and favors kidney stone formation. To understand the molecular basis of uric acid transport and the role of disease-causing mutations in SLC2A9, we determined structures of human SLC2A9 in its apo form, and its urate-bound form by cryo-EM, at resolution of 3.3 Å and 4.1 Å respectively. Both structures are captured in an inward open conformation. Using the inward-facing structure as a template we modeled the outward-facing conformation to understand the alternating access mechanism. Alternative salt bridge pairs on the cytoplasmic side suggest a mechanism that can balance the energetics of the inward open and outward open states. The location of disease-causing mutants suggests their role in impacting function. Our structures elucidate the molecular basis for urate selectivity and transport and provide a platform for future structure-based drug discovery aimed at reducing plasma urate levels in diseases of hyperuricemia and gout. | |||||||||
| 履歴 |
|
-
構造の表示
| 添付画像 |
|---|
-
ダウンロードとリンク
-EMDBアーカイブ
| マップデータ | emd_45406.map.gz | 167.9 MB | EMDBマップデータ形式 | |
|---|---|---|---|---|
| ヘッダ (付随情報) | emd-45406-v30.xml emd-45406.xml | 25.1 KB 25.1 KB | 表示 表示 | EMDBヘッダ |
| FSC (解像度算出) | emd_45406_fsc.xml | 11.9 KB | 表示 | FSCデータファイル |
| 画像 | emd_45406.png | 49.1 KB | ||
| マスクデータ | emd_45406_msk_1.map | 178 MB | マスクマップ | |
| Filedesc metadata | emd-45406.cif.gz | 7 KB | ||
| その他 | emd_45406_additional_1.map.gz emd_45406_half_map_1.map.gz emd_45406_half_map_2.map.gz | 88.3 MB 165.2 MB 165.2 MB | ||
| アーカイブディレクトリ | http://ftp.pdbj.org/pub/emdb/structures/EMD-45406 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-45406 | HTTPS FTP |
-検証レポート
| 文書・要旨 | emd_45406_validation.pdf.gz | 799.3 KB | 表示 | EMDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | emd_45406_full_validation.pdf.gz | 798.9 KB | 表示 | |
| XML形式データ | emd_45406_validation.xml.gz | 20.7 KB | 表示 | |
| CIF形式データ | emd_45406_validation.cif.gz | 26.9 KB | 表示 | |
| アーカイブディレクトリ | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-45406 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-45406 | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 9caxMC ![]() 9cbbC M: このマップから作成された原子モデル C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
-
リンク
| EMDBのページ | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| 「今月の分子」の関連する項目 |
-
マップ
| ファイル | ダウンロード / ファイル: emd_45406.map.gz / 形式: CCP4 / 大きさ: 178 MB / タイプ: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注釈 | Sharpen final map after refinement | ||||||||||||||||||||||||||||||||||||
| 投影像・断面図 | 画像のコントロール
画像は Spider により作成 | ||||||||||||||||||||||||||||||||||||
| ボクセルのサイズ | X=Y=Z: 0.8189 Å | ||||||||||||||||||||||||||||||||||||
| 密度 |
| ||||||||||||||||||||||||||||||||||||
| 対称性 | 空間群: 1 | ||||||||||||||||||||||||||||||||||||
| 詳細 | EMDB XML:
|
-添付データ
-マスク #1
| ファイル | emd_45406_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 投影像・断面図 |
| ||||||||||||
| 密度ヒストグラム |
-追加マップ: Unsharpen final map after refinement
| ファイル | emd_45406_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注釈 | Unsharpen final map after refinement | ||||||||||||
| 投影像・断面図 |
| ||||||||||||
| 密度ヒストグラム |
-ハーフマップ: Half map A
| ファイル | emd_45406_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注釈 | Half map A | ||||||||||||
| 投影像・断面図 |
| ||||||||||||
| 密度ヒストグラム |
-ハーフマップ: Half map B
| ファイル | emd_45406_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注釈 | Half map B | ||||||||||||
| 投影像・断面図 |
| ||||||||||||
| 密度ヒストグラム |
-
試料の構成要素
-全体 : Codon optimize SLC2A9 gene was synthesize and cloned in 83 nu yea...
| 全体 | 名称: Codon optimize SLC2A9 gene was synthesize and cloned in 83 nu yeast expressing vector from GenScript. Protein expressed in yeast cells and purified using Ni-affinity followed by Sizing. |
|---|---|
| 要素 |
|
-超分子 #1: Codon optimize SLC2A9 gene was synthesize and cloned in 83 nu yea...
| 超分子 | 名称: Codon optimize SLC2A9 gene was synthesize and cloned in 83 nu yeast expressing vector from GenScript. Protein expressed in yeast cells and purified using Ni-affinity followed by Sizing. タイプ: complex / ID: 1 / 親要素: 0 / 含まれる分子: all |
|---|---|
| 由来(天然) | 生物種: Homo sapiens (Human) (ヒト) |
| 分子量 | 理論値: 69.78906 KDa |
-分子 #1: Soluble cytochrome b562,Solute carrier family 2, facilitated gluc...
| 分子 | 名称: Soluble cytochrome b562,Solute carrier family 2, facilitated glucose transporter member 9 タイプ: protein_or_peptide / ID: 1 詳細: N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag ...詳細: N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag,N-terminal Flag tag, HRV3C site followed by BRIL tag N-terminal truncated SlC2A9 isoform 1 (residue 52-540 as per uniprot). C terminal thrombin site followed by 10X his tag コピー数: 1 / 光学異性体: LEVO |
|---|---|
| 由来(天然) | 生物種: Homo sapiens (ヒト) |
| 分子量 | 理論値: 69.859695 KDa |
| 組換発現 | 生物種: ![]() |
| 配列 | 文字列: MASDYKDDDD KGALEVLFQG PSSPMADLED NWETLNDNLK VIEKADNAAQ VKDALTKMRA AALDAQKATP PKLEDKSPDS PEMKDFRHG FDILVGQIDD ALKLANEGKV KEAQAAAEQL KTTRNAYIQK YLSCSLLVAS LAGAFGSSFL YGYNLSVVNA P TPYIKAFY ...文字列: MASDYKDDDD KGALEVLFQG PSSPMADLED NWETLNDNLK VIEKADNAAQ VKDALTKMRA AALDAQKATP PKLEDKSPDS PEMKDFRHG FDILVGQIDD ALKLANEGKV KEAQAAAEQL KTTRNAYIQK YLSCSLLVAS LAGAFGSSFL YGYNLSVVNA P TPYIKAFY NESWERRHGR PIDPDTLTLL WSVTVSIFAI GGLVGTLIVK MIGKVLGRKH TLLANNGFAI SAALLMACSL QA GAFEMLI VGRFIMGIDG GVALSVLPMY LSEISPKEIR GSLGQVTAIF ICIGVFTGQL LGLPELLGKE STWPYLFGVI VVP AVVQLL SLPFLPDSPR YLLLEKHNEA RAVKAFQTFL GKADVSQEVE EVLAESRVQR SIRLVSVLEL LRAPYVRWQV VTVI VTMAC YQLCGLNAIW FYTNSIFGKA GIPPAKIPYV TLSTGGIETL AAVFSGLVIE HLGRRPLLIG GFGLMGLFFG TLTIT LTLQ DHAPWVPYLS IVGILAIIAS FCSGPGGIPF ILTGEFFQQS QRPAAFIIAG TVNWLSNFAV GLLFPFIQKS LDTYCF LVF ATICITGAIY LYFVLPETKN RTYAEISQAF SKRNKAYPPE EKIDSAVTDG KINGRPGLVP RGSSAHHHHH HHHHHGA UniProtKB: Soluble cytochrome b562, Solute carrier family 2, facilitated glucose transporter member 9 |
-実験情報
-構造解析
| 手法 | クライオ電子顕微鏡法 |
|---|---|
解析 | 単粒子再構成法 |
| 試料の集合状態 | particle |
-
試料調製
| 濃度 | 7 mg/mL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 緩衝液 | pH: 7.5 構成要素:
詳細: 4 degree cold buffer pH7.5 (300mM NaCl, 50mM Tris and 0.02% GDN) | |||||||||
| グリッド | モデル: Quantifoil R1.2/1.3 / 材質: GOLD / メッシュ: 400 / 支持フィルム - 材質: CARBON / 支持フィルム - トポロジー: HOLEY / 前処理 - タイプ: GLOW DISCHARGE / 前処理 - 時間: 30 sec. / 前処理 - 気圧: 0.033 kPa / 詳細: 30 second glow 30 sec hold | |||||||||
| 凍結 | 凍結剤: ETHANE / チャンバー内湿度: 100 % / チャンバー内温度: 277.15 K / 装置: FEI VITROBOT MARK IV |
-
電子顕微鏡法
| 顕微鏡 | FEI TITAN KRIOS |
|---|---|
| 撮影 | フィルム・検出器のモデル: GATAN K3 (6k x 4k) / 撮影したグリッド数: 1 / 実像数: 10503 / 平均露光時間: 2.0 sec. / 平均電子線量: 47.7 e/Å2 |
| 電子線 | 加速電圧: 300 kV / 電子線源: FIELD EMISSION GUN |
| 電子光学系 | C2レンズ絞り径: 70.0 µm / 照射モード: FLOOD BEAM / 撮影モード: OTHER / Cs: 2.7 mm / 最大 デフォーカス(公称値): 2.0 µm / 最小 デフォーカス(公称値): 1.0 µm |
| 試料ステージ | ホルダー冷却材: NITROGEN |
| 実験機器 | ![]() モデル: Titan Krios / 画像提供: FEI Company |
ムービー
コントローラー
万見について




キーワード
Homo sapiens (Human) (ヒト)
データ登録者
米国, 1件
引用











Z (Sec.)
Y (Row.)
X (Col.)





















































解析
FIELD EMISSION GUN

